Eagle Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,286
Closed -$268K 593
2021
Q2
$268K Sell
6,286
-178
-3% -$7.49K ﹤0.01% 577
2021
Q1
$249K Buy
+6,464
New +$245K ﹤0.01% 574
2020
Q4
Sell
-8,470
Closed -$319K 577
2020
Q3
$319K Sell
8,470
-608
-7% -$23.4K ﹤0.01% 535
2020
Q2
$314K Buy
+9,078
New +$327K ﹤0.01% 534

Other funds holding BSX

Eagle Asset Management's BSX Position: Q3 2021 in Review

Eagle Asset Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 6,286 shares — an estimated $268K sold.

Eagle Asset Management first reported a position in BSX in Q2 2020 and held it in 4 quarters. The position peaked at $319K in Q3 2020. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Eagle Asset Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
  • Eagle Asset Management sold 6,286 Boston Scientific shares in Q3 2021, an estimated $268K.
  • Eagle Asset Management first reported a position in Boston Scientific in Q2 2020 and held it in 4 quarters.
  • Eagle Asset Management's Boston Scientific position peaked at $319K in Q3 2020.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Eagle Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.